[New post] Iran’s Universal Healthcare: Equity or Missed Opportunity

etasdig1 posted: " In 2014, Iran rolled out a grand vision for a universal healthcare insurance. Hailed as a landmark reform by the Ministry of Health, the policy aimed to democratize healthcare access across the nation. However, nine years down the line, it's time to exam" Social, Cultural & Behavioral Issues in PHC & Global Health Iran's Universal Healthcare: Equity or Missed Opportunity etasdig1 Aug 31 In 2014, Iran rolled out a grand vision for a universal healthcare insurance. Hailed as a landmark reform by the Ministry of Health, the policy aimed to democratize healthcare access across the nation. However, nine years down the line, it's time to examine the prescription. Despite decades of policy interventions, Iran's progress toward Universal Health Coverage remains suboptimal in critical dimensions such as equitable access, service coverage, and financial protection. Instituted in 2014, the Health Transformation Plan sought to ameliorate these deficiencies. The plan facilitated an expansion of coverage, encompassing an additional 11 million previously uninsured individuals, predominantly from the self-employed sector. Moreover, it aimed to alleviate out-of-pocket expenditures in public healthcare facilities. Financial underpinnings for the Health Transformation Plan were sourced from targeted subsidies and a portion of the value-added tax. Iran's healthcare plan has had some success but also faces big challenges, especially in paying for the program in the long term. To improve healthcare for everyone, government departments need to work together to control costs, which could include measures like broadening family doctor programs and setting up clear treatment guidelines. The reality was that the costs weren't managed well, and the government may have to cut free healthcare or make people pay more, making healthcare harder to access for many. As a result, following the National Health Accounts, out of pocket expenses for the whole population increased from 46.2% in 2003 to 53.8% of total health care expenditures in 2008. Additionally, a lot of outpatient and basic health services in Iran are provided by private hospitals, which can be expensive and aren't covered by the government plan. This makes it crucial for the government to improve public hospitals, especially in poorer areas. Balancing the costs between public and private healthcare is important. With extra financial challenges like international sanctions and the COVID-19 pandemic, it's even more important to think carefully about how to make healthcare affordable and sustainable for the long run. To make healthcare better in Iran, it's important for government ministries to work together to control costs. They could expand the family doctor program to more areas and make sure treatments are cost-effective. It's also important to improve public hospitals, especially in poorer areas, to take the pressure off expensive private ones. To fund all of this fairly and keep it going long-term, the government needs a clear payment plan, especially given extra challenges like international sanctions and COVID-19. Regular checks should be made to see if the plan is working. Comment Like You can also reply to this email to leave a comment. Unsubscribe to no longer receive posts from Social, Cultural & Behavioral Issues in PHC & Global Health. Change your email settings at manage subscriptions. Trouble clicking? Copy and paste this URL into your browser: https://sbfphc.wordpress.com/2023/08/31/irans-universal-healthcare-equity-or-missed-opportunity/

Get the Jetpack app to use Reader anywhere, anytime Follow your favorite sites, save posts to read later, and get real-time notifications for likes and comments. Automattic, Inc. - 60 29th St. #343, San Francisco, CA 94110

[New post] Stephen W. Schondelmeyer, PharmD, PhD

Marquis Who's Who Moderator posted: "Title: Professor Company: College of Pharmacy, University of Minnesota Location: Woodbury, Minnesota, United States Stephen W. Schondelmeyer, PharmD, PhD, Professor in the University of Minnesota College of Pharmacy, has been recognized by Marquis Who'" Marquis Who's Who Top Educators Stephen W. Schondelmeyer, PharmD, PhD Marquis Who's Who Moderator Sep 1 Title: Professor Company: College of Pharmacy, University of Minnesota Location: Woodbury, Minnesota, United States Stephen W. Schondelmeyer, PharmD, PhD, Professor in the University of Minnesota College of Pharmacy, has been recognized by Marquis Who's Who Top Educators for dedication, achievements, and leadership in pharmacy education. For more than 20 years, Dr. Schondelmeyer has excelled as a professor with the University of Minnesota. As an educator in the College of Pharmacy's department of pharmaceutical care and health systems, he bears specific expertise in legal, economic and policy issues related to drugs. During his career, he has been responsible for supervising more than 30 faculty members, ranging from practitioners to clinical pharmacists. While working at the University of Minnesota, Dr. Schondelmeyer dedicated his efforts as the head of the department of pharmaceutical care and health systems. Alongside his work as a professor, he has been a member of the Minnesota Policy Group and served as the director of the PRIME Institute. Dr. Schondelmeyer was also the Century Mortar Club Endowed Chair in pharmaceutical management and economics and a co-principal investigator with the Center for Infectious Disease Research and Policy's Resilient Drug Supply Project. To prepare for his career, Dr. Schondelmeyer graduated from the University of Missouri with a Bachelor of Science in pharmacy in 1974. In 1977, he earned a Doctor of Pharmacy from the University of Kentucky, and in 1979, he obtained a Master of Public Administration from The Ohio State University. Dr. Schondelmeyer concluded his higher education at The Ohio State University, graduating in 1984 with a Doctor of Philosophy in pharmaceutical administration. Adjacent to his primary endeavors, Dr. Schondelmeyer has found success as a researcher for "Upstream Supply Chain for Drugs." He conducted numerous research projects and additionally served as an adviser to the U.S. Congress for the Medicare Catastrophic Coverage Act of 1988. For his accomplishments, Dr. Schondelmeyer has received numerous awards and accolades. In his spare time, he enjoys reviewing data, monitoring trends in his field, and traveling. Contact Dr. Schondelmeyer: Comment Unsubscribe to no longer receive posts from Marquis Who's Who Top Educators. Change your email settings at manage subscriptions. Trouble clicking? Copy and paste this URL into your browser: https://marquistopeducators.com/2023/09/01/stephen-schondelmeyer/

Get the Jetpack app to use Reader anywhere, anytime Follow your favorite sites, save posts to read later, and get real-time notifications for likes and comments. Automattic, Inc. - 60 29th St. #343, San Francisco, CA 94110